Under construction – not a live service
Sign in

Sarcoma trials, also abroad

In India 2Also abroad 605

605 open Sarcoma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States300
China106
France72
Italy52
Spain40
All other countries

The same trial often runs in several countries

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) has 4 sites in India and runs in 30 countries. If a site near you is full, another one may still take people.

See A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) in all 30 countries